Optum guides providers through important upcoming formulary updates
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
October 11, 2017 – The FDA approved updates to the Warnings and Precautions section of the Alimta (pemetrexed) drug label.
Download PDF
Return to publications
